乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Chemotherapy

News, opinions and meeting coverage in oncology/hematology.

Fludarabine, cyclophosphamide, and rituximab over a chronic lymphocytic leukemia (CLL) blood smear under light microscopy

<乌鸦传媒>FCR Still an Option in IGHV-Unmutated CLL?

Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit

ESMO over a photo of FIRA Barcelona, Spain

<乌鸦传媒>Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer

Misses primary endpoints but has unexpected key benefit

The bottle and packaging of Imbruvica over an electrocardiogram

<乌鸦传媒>Ibrutinib's Cardiotoxicity Comes Into Focus

Study identifies new cardiac events linked to so-called targeted therapy

ASTRO over a photo of McCormick Place West, Chicago

<乌鸦传媒>Tx Deintensification Wins in Head and Neck Cancer, But ...

Only against another less-intensive approach in HPV-positive disease

WCLC over a photo of Gran Via, Fira de Barcelona

<乌鸦传媒>'Dirtier' Drugs Step Aside in RET-Positive NSCLC

Over two-thirds of patients respond to selective RET inhibitor

A woman receiving chemotherapy

<乌鸦传媒>Total Chemo Dose Still Matters in Breast Cancer

Worse survival with cumulative dose

ASCO over a photo of McCormick Place in Chicago.

<乌鸦传媒>Depth of Tumor Response a Better Survival Predictor

Could improve on RECIST as outcome measure in oncology

Computer rendering of breast cancer.

<乌鸦传媒>Omitting Chemo Feasible in First-Line HER2+ Breast Cancer?

De-escalation showed mixed results in metastatic disease

Three bottles of 鈥淢agic Mouthwash.鈥�

<乌鸦传媒>'Magic Mouthwash' Little Help for Radiation-Induced Mucositis

Only statistical improvements in pain scores for head and neck cancer patients

Sheraton Grand hotel in Chicago with ACR-SOTA text overlaid.

<乌鸦传媒>Rheumatologist's Primer on Checkpoint Inhibitors

Specialist reviews the landscape of cancer drugs' autoimmune side effects

A photo of the Georgia World Conference Center with the acronym AACR overlaid.

<乌鸦传媒>PARP Inhibitor Maintenance for Pancreatic Cancer

Study takes cue from new treatment paradigm in BRCA-mutant ovarian cancer

A photo of the Georgia World Conference Center with the acronym AACR overlaid

<乌鸦传媒>Reversing Melanoma Resistance to Immunotherapy

HDAC inhibitor/anti-PD-1 combo active after initial anti-PD-1 failure

A photo of the Georgia World Conference Center with the acronym AACR overlaid.

<乌鸦传媒>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC

Savolitinib promising in patients with MET-based resistance to EGFR inhibition

An elderly dying man receives medication from a small cup.

<乌鸦传媒>Aggressive Tx Remains Common for Adults, Children Near Death

Many patients continue with treatments they probably don't need

<乌鸦传媒>Early Data Send Strong Signal in Advanced Gyn Cancers

Clinical benefit rate tops 90% in pair of single-center studies

<乌鸦传媒>When PARP Inhibitors Fail in Ovarian Cancer

Study identifies subgroup for whom another go could be worthwhile

<乌鸦传媒>Avelumab Combo Falls Short in Advanced Ovarian Ca

But showed promise in PD-L1-positive group

<乌鸦传媒>Zytiga May Up Mortality Risk in Prostate Cancer Patients With CVD

Increased hospitalizations seen among all abiraterone-treated patients

<乌鸦传媒>Genetic Profiling Disappoints for CUP Survival

But testing in cancer of unknown primary site did help with prognosis

<乌鸦传媒>Surgery/HIPEC Safer Than Other High-Risk Cancer Procedures

Lower infection, 30-day mortality rates than with Whipple, esophagectomy

<乌鸦传媒>Cancer Treatment and Arthritis: A Growing Complaint

Will checkpoint inhibitor-related arthritis outstrip RA in frequency?

<乌鸦传媒>Higher Risk of Shingles Seen in Patients With Certain Cancers

Vaccine development may help with prevention of herpes zoster in this population

<乌鸦传媒>Visual Guide to AVERT's VTE Prevention in Cancer

Apixaban effective against important chemotherapy side effect

<乌鸦传媒>Low-Dose Tamoxifen Feasible Option in Breast Cancer

Women appear to prevent recurrence in early stage cancers with 5 mg dosing

<乌鸦传媒>Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Ca

Cetuximab resulted in more patient deaths across U.S., German studies

<乌鸦传媒>Study: Paclitaxel Best for HIV-Related Kaposi's Sarcoma

Other chemotherapies fall behind in resource-limited setting

<乌鸦传媒>Is Drug Vial Optimization in Peril? Pharmacy Practice News

Also, how to advance your leadership skills

<乌鸦传媒>Ditching Chemo Appears Viable in Frontline Follicular Lymphoma

PFS 'nearly identical' at 3 years with novel immunomodulatory combination

<乌鸦传媒>PFS Rises in Ovarian Ca with Repeat Bevacizumab

Magnitude of benefit similar to first-line therapy

<乌鸦传媒>Many with Metastatic Kidney Cancer Can Skip Surgery

Overall survival with single-agent sunitinib better than with resection

<乌鸦传媒>Hot Chemo Fails in Rare Cancer

HIPEC and surgery equals surgery alone in peritoneal carcinomatosis

<乌鸦传媒>Rare Childhood Cancer Gets First Tx Advance in 30 Years

But impact unclear for U.S. rhabdomyosarcoma patients

<乌鸦传媒>Keytruda Alone Bests Chemo in Advanced NSCLC

Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations

<乌鸦传媒>Chemo-Induced Neuropathy Common after Childhood Cancer

Neurotoxicity more prevalent in children treated with cisplatin

<乌鸦传媒>Make the Diagnosis: What鈥檚 to Blame for his Rash and Paresthesia?

Case Findings: A 52-year-old man who was undergoing chemotherapy for leukemia went to the ED 5 days after receiving cytarabine. He complained of a rapid onset of erythematous lesions on his palms and soles accompanied by tingling and burning sensations. Can you diagnose the patient?

<乌鸦传媒>Vince DeVita鈥檚 Oncology Opus

Medicine and music share center stage in storied career

<乌鸦传媒>'A Very Dangerous Interpretation': What We Heard This Week

Quotable quotes from 乌鸦传媒's sources

<乌鸦传媒>MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

<乌鸦传媒>'Jurassic' Clinical Trial Yields Prostate Cancer Guidance

Negative trial informs new studies of adjuvant therapy

<乌鸦传媒>PET-Guided Therapy Switch for Esophageal Cancer

Improved response with switch from ineffective treatment

4